Gordon Tomaselli, Johns Hopkins School of Medicine
Gordon Tomaselli commented on Volker Schächinger’s findings at the Dallas meeting of the American Heart Association.
[audio:https://www.audiomedica.com/podcasting/aha2005/Tomaselli_Schachinger.mp3]
Novel oral anticoagulants: latest opinion from the ESC congress 22 Sep, 2013 
COURAGE Trial: Optimal Medical Therapy Alone is Sufficient for Patients with Stable Angina: Adding PCI Does Not Help – ILLUSTRATE Study Shows Torcetrapib Raises HDL But Fails to Lower Coronary Risk 26 Mar, 2007 ENDEAVOR or Cypher? Comparison of Drug Eluting Stents 17 Nov, 2005 Drug-eluting Stents: Cost-Benefit Targeting? 12 Sep, 2005 
COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014